e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Jessica Carter, Jon S. Friedland, Daniela E. Kirwan, Ruvandhi R. Nathavitharana
Source:
ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Journal Issue:
October
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jessica Carter, Jon S. Friedland, Daniela E. Kirwan, Ruvandhi R. Nathavitharana. Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis. ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016
Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster
Source: Eur Respir J 2014; 43: 1563-1566
Year: 2014
Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances
Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017
Year: 2017
Advancing preparedness for clinical research during infectious disease epidemics
Source: ERJ Open Res, 5 (2) 00227-2018; 10.1183/23120541.00227-2018
Year: 2019
Crowdfunding for respiratory research: a new frontier for patient and public engagement?
Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017
Year: 2017
Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017
How to optimise patient and public involvement in your research: Doing science
Source: Breathe 2015; 11:223-227
Year: 2015
Ebola: challenges for public health – what have we learnt?
Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning
Year: 2015
Using a rapid prioritisation process to identify health research priorities in LMICs
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Role of research in preparedness and response to emerging disease threats in Europe
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017
Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012
A global strategy for tuberculosis research and innovation
Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
Year: 2020
Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis
Source: Eur Respir J 2014; 44: 5-7
Year: 2014
Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions
Source: Eur Respir J 2016; 48: 1545-1548
Year: 2016
Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives
Source: Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017
Year: 2017
From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013
Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective
Source: Breathe 2015; 11:71-72
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept